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• Granulomatous rosacea has a background of erythema and telangiectasia and can have extra-facial lesions; these are uncommon in lupus miliaris disseminatus faciei • Sarcoidosis can have associated systemic involvement while lupus miliaris disseminatus faciei does not • Sudden eruption of dome-shaped papules and nodules in a leprosy patient with resistance to dapsone having characteristic epidermal Grenz zone and dermal spindle-shaped histiocytes characterizes histoid leprosy, whereas lupus miliaris disseminatus faciei shows perifollicular epithelioid cell granulomas with Langhans giant cells and occasionally caseation necrosis.
What are the idiopathic facial granulomatous eruptions and what are their differentiating features?
The salient differentiating features of idiopathic facial granulomatous eruptions are outlined in Table 1 .
THERAPEUTIC PARADOX THERAPEUTIC PARADOX
What is a "therapeutic paradox?" A "paradox" is defined as a "seemingly absurd or contradictory statement or proposition which when investigated may prove to be well founded or true."
When a drug is given for the treatment of a particular condition, paradoxically, it is also responsible for the causation/exacerbation of the condition; this is called as a "therapeutic paradox."
Enumerate some "therapeutic paradoxes" in dermatology • Tumor necrosis factor alpha inhibitor-induced psoriasis
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The differentials in this case include lupus miliaris disseminatus faciei, acne, granulomatous rosacea and sarcoidosis.
What are the synonyms for lupus miliaris disseminatus faciei?
The other terminologies are acne agminata, acnitis, Lewandowsky's rosaceiform eruption and facial idiopathic granulomas with regressive evolution. Itching is a consistent symptom in lichen planus, but paradoxically excoriations are conspicuously absent as the patient rubs rather than scratches to gain relief and hence the pathognomonic lesion morphology and Wickham's striae are preserved (Brocq's phenomenon) • In cases of co-infection of leprosy and human immunodeficiency virus, the clinical, immunological and pathological features are same even in progressive human immunodeficiency virus disease and granuloma formation remains well preserved even with declining T-cell mediated immunity -the so-called "granuloma paradox."
Adapted from and for further reading: Adya KA, Inamdar AC, Palit A. Paradoxes in dermatology. Indian Dermatol Online J 2013; 4:133-42 .
TRICHOSCOPY CROSSWORD TRICHOSCOPY CROSSWORD
Identify the condition and solve the crossword puzzle [ Figure 2 ] based on the trichoscopic clues [Box 1]. Answers to the crossword puzzle are provided in Figure 3 on page 118.
LESER-TRELAT SIGN LESER-TRELAT SIGN
What is sign of Leser-Trelat?
The sign of Leser-Trelat is characterized by the sudden eruption of numerous seborrheic keratoses, often with associated pruritus, or a rapid increase in their size within weeks or months. It is considered a marker of internal malignancy.
Enumerate the conditions wherein the sign of Leser-Trelat is found. This sign has been described with various malignancies such as stomach cancer, gastrointestinal adenocarcinoma, lymphoma, leukemia, mycosis fungoides, Sezary syndrome, breast carcinoma, lung carcinoma, prostate carcinoma, laryngeal carcinoma and sarcomas (neurofibrosarcoma). The sign has been also reported in non-malignant situations as in heart transplant recipients, erythrodermic pityriasis rubra pilaris and human immunodeficiency virus infection; it can also occur in normal persons.
KASABACH-MERRITT SYNDROME KASABACH-MERRITT SYNDROME
What is Kasabach-Merritt syndrome or Kasabach-Merritt phenomenon? Kasabach-Merritt phenomenon is characterized by a rapidly enlarging vascular tumor associated with thrombocytopenia, microangiopathic hemolytic anemia and a consumptive coagulopathy. Kasabach-Merritt phenomenon should be suspected in case of a rapidly enlarging vascular tumor associated with sudden appearance of ecchymoses which may extend beyond the margins of the tumor. There is a woody texture and the overlying inflammation may appear cellulitic. There is a bleeding diathesis that may manifest with hematuria, epistaxis and prolonged bleeding at sites of trauma. There is thrombocytopenia and activation of the fibrinolytic system. Due to the disseminated intravascular coagulation, there is consumption of clotting factors, low fibrinogen levels, elevated D-dimers, elevated prothrombin time and activated partial thromboplastin time.
What are the treatment options in Kasabach-Merritt phenomenon?
The treatment options depend on the severity of the coagulation defect, the site of tumor and the presence or absence of the physical effects of compression of surrounding tissues.
Initial conservative management with regular monitoring of platelets, clotting studies, fibrinogen and D-dimers should be done. Platelet transfusions and systemic corticosteroids should initially be used. Tumor reduction can be done with cytotoxic therapy, interferons. Surgical treatment (with pre-embolization) and radiotherapy can be considered in difficult cases.
EOSINOPHILIC FASCIITIS EOSINOPHILIC FASCIITIS
What is the synonym of eosinophilic fasciitis? This scleroderma-like syndrome is also termed as Shulman's syndrome. It is an uncommon connective tissue disease that may mimic and overlap with other sclerosing disorders such as morphea and lichen sclerosus. Clinical Sudden-onset erythema, edema in the early phase and symmetrical woody induration of the distal extremities later are characteristic. There is a limitation of movement of the feet and hands. Occasionally, the face or abdomen can be affected and there may be superficial blistering and hemorrhage.
Histology
There is dermal sclerosis with inflammation and fibrosis extending to the subcutaneous tissue and deep fascia. The fascia is thickened and infiltrated with lymphocytes, plasma cells, histiocytes and eosinophils. Immunoglobulin G and C3 deposits can be demonstrated in the deep fascia. The inflammatory infiltrate consists of macrophages and predominantly CD8+ T-cells with eosinophils.
Investigations
Blood eosinophilia (up to 30%) is the predominant feature in most patients. Erythrocyte sedimentation rate may be elevated. There may be hyperglobulinemia, rarely, aplastic anemia and thrombocytopenia may be seen. Magnetic resonance imaging shows thickened deep fasciae on T1-weighted sequences and relatively increased signal intensity greater than that of muscle on fat-suppressed or fat-saturated T2-weighted sequences. 
PHOTODYNAMIC THERAPY PHOTODYNAMIC THERAPY
What is the mechanism of photodynamic therapy? Photodynamic therapy involves treatment with 5-aminolevulenic acid and various sources of light. There is absorption of 5-aminolevulenic acid by the rapidly proliferating epidermal and dermal cells and it is metabolized to the active photosensitizer, protoporphyrin IX, via the heme biosynthesis pathway. When protoporphyrin IX is activated by light, photodynamic reactions occur that lead to cell necrosis, apoptosis and remodulation.
What are the uses of topical photodynamic therapy in dermatology? Topical photodynamic therapy with 5-aminolevulinic acid is a promising therapeutic modality for proliferative diseases such as actinic keratosis, Bowen's disease, in situ squamous cell carcinoma and superficial basal cell carcinoma. It has also been used in recalcitrant warts and warts in difficult to treat sites such as urethral condyloma acuminata. Photodynamic therapy is also being used in acne and as a photorejuvenation therapy.
LEOPARD SYNDROME LEOPARD SYNDROME
What are the various clinical types of lentiginosis?
The term lentiginosis is used when there are numerous or extensive lentigenes, or they have a characteristic clinical pattern. 
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